Liposomal: Plausible Bet, Unsettled Science, Settled Pricing

The claim, the evidence, and the asymmetry between them

This is the audit the whole premium tier links back to, so it runs complete. The liposomal claim: encapsulating GSH in lipid vesicles shields it through digestion and enhances absorption — mechanically plausible, elegantly diagrammed, and the entire justification for £1.20-1.80/day pricing. The supporting evidence, sized honestly: smaller and shorter studies, mostly measuring plasma or short-window markers, some showing favourable liposomal numbers — suggestive, genuinely, and structurally weak where it matters, because plasma windows were exactly the wrong lens that made early plain-GSH research look falsely negative (that history's whole lesson). The asymmetry that decides the audit: the category's foundational finding — body stores rising progressively over six months — came from plain non-liposomal capsules; the premium format has never been shown superior on that endpoint, over that duration, head-to-head. Plausible bet, unsettled science, settled pricing: the three-part status this cluster refuses to let marketing collapse into one word.

The missing trial — and how to shop until it exists

What would actually settle it, specified so the gap is visible: liposomal versus plain GSH, randomised, months long, with body stores as the endpoint — the foundational trial's own design applied to the format war. It hasn't been run, and until it is, mechanism diagrams and plasma studies remain suggestive rather than settling — which converts into shopping guidance cleanly: the premium is worth paying only by buyers who can name what they're buying — the mechanism bet itself (a defensible speculative position, taken knowingly), or the format experience (sachets solving real capsule-fatigue, the adherence case Zooki's review credits fully, and Altrient's at the ceiling) — and not worth paying as a default, because defaults should follow the evidence's own route, and the evidence walked through plain capsules (the format map, the dedicated format fork to come).

The plain-first default — the trial's route at the honest floor, upgradeable if evidence ever demands

Futuro Labs Glutathione

★ 5/5

£22.99 for 30-day supply · 77p per day

Futuro Labs Glutathione delivers 500mg of reduced glutathione (GSH) per serving — the active, research-referenced form, not a precursor blend. Manufactured in the UK under UK GMP accreditation, the highest food-safety grade in British supplement manufacturing. Single-ingredient, vegan capsules, no fillers, independently lab tested for microbiological purity and heavy metals. A 30-day supply at £22.99 works out to roughly 77p per day — a fraction of the cost of liposomal formats like Zooki or Altrient, which typically run £35-55 per month.

Pros

• 500mg reduced glutathione (GSH) per serving — the active form
• UK manufactured under GMP certification
• Single-ingredient, vegan, no fillers
• Independently lab tested — microbiology and heavy metals
• ~77p per day vs £1.20-1.80/day for liposomal formats

Cons

• Capsule format — no liposomal delivery system
• Newer brand versus heritage names like Solgar

Available from: Amazon UK — £22.99

The plain-first protocol — and what the spread funds instead

The sensible default, specified: Futuro Labs Glutathione at 500mg plain reduced glutathione daily — the tested form at the studied window's middle, single-ingredient vegan capsules, independent heavy-metals and microbiology testing shown, £22.99/30 days at ~77p — run on the standard clock (8-12 weeks minimum, full curve at 3-6 months — the timeline) with the standard review (every few months: still earning its place?). What the £13-31 monthly spread funds instead, ranked as ever: nothing at all (a fine answer), or the inputs that outpull any format — protein quality, the sleep the whole system repairs on, the not-smoking and moderate-drinking levers with actual depletion literature behind them (the hierarchy, the real loads). And the upgrade clause, held open honestly: if the settling trial ever arrives and favours the vesicles, stores strategies transfer without ceremony — switch formats, keep the clock, nothing lost by having defaulted to evidence meanwhile. Gates unchanged by any format: pregnancy/breastfeeding → medical advice; prescription medication → pharmacist minute (the routing). Worth it, answered at its honest size: for the knowing bettor, maybe; for the default buyer, not yet — and 'not yet' is a complete sentence this page is content to end on.

Frequently asked questions